Navigation path

Login   |   Register

Advanced search Search in:    Audio    Photo    Video    Shotlist


Search video result(s)

Sort by
591 Results
 1  of  60 
Ref: I-149288
Date: 11/01/2018

Ref: I-149292
Date: 11/01/2018

Ref: I-148887
Date: 20/12/2017
Participation of Vytenis Andriukaitis, Member of the EC, in the EIB signing ceremony Investment Plan for Europe
On 21 December 2017, The European Investment Bank (EIB) provided a loan of 40 million euros to Indivumed GmbH and of 25 million euros to AMW GmbH. Indivumed GmbH, a physician-led, is an integrated global oncology company providing high-content tumour data and an optimum quality biobank to third parties such as biopharmaceutical companies and research institutes. The EIB funding will allow Indivumed to develop and validate new assays biomarker for the Biobank business and technology platforms. In addition, the Company is aiming at building a unique “Global Cancer Database Solution“ which would support cancer researchers worldwide by providing access to data from cancer patients, as well as bioinformatic tools to better understand complex cancer data.AMW GmbH (AMW) is a German pharmaceutical company specialised in the development and manufacturing of innovative drug delivery systems.The financing will support AMW in Warngau, Bavaria, and its subsidiary Endomedica in Halle, Saxony-Anhalt, enabling them to increase R&D activities, conduct clinical trials and expand production capacity. This will be achieved with a new building located at the head office in Warngau to house research, development and production facilities complimented by purpose-built manufacturing technology and state-of-the-art laboratory equipment.These two financing were made possible by the support of the European Fund for Strategic Investments (EFSI).This video shows the signature ceremony of these two projects and statements given on this occasion by Ambroise Fayolle, Vice-President of the European Investment Bank (EIB) responsible for Innovation, Vytenis Andriukaitis, Member of the EC in charge of Health and Food Safety, Wilfried Fischer, Managing Director of AMW, and Hartmut Juhl, Founder and CEO of Indivumed Group.

Ref: I-148972
Date: 19/12/2017

Ref: I-147096
Date: 23/11/2017

Ref: I-145481
Date: 27/10/2017

Ref: I-145478
Date: 27/10/2017

Ref: I-145812
Date: 26/10/2017

Ref: I-144188
Date: 26/09/2017

Ref: I-144176
Date: 26/09/2017

591 Results
 1  of  60 

You don't find what you are looking for? Ask us!

Go to useful links page Useful links

Go to rss page Go to EU Tube page Go to twitter page Go to facebook page Go to contact page

Credit © European Union, 2018